Psyence Biomedical (PBM) has released an update.
Psyence Biomedical Ltd. has issued a Senior Secured Convertible Note due July 15, 2027, with a principal amount of $312,500 and an initial loan amount of $250,000. The note is convertible under certain conditions and is not registered with the SEC, meaning it can only be traded in compliance with specific registration exemptions. Additionally, trading restrictions apply under Canadian securities legislation, which prohibits trading of the security before a set date post-issuance.
For further insights into PBM stock, check out TipRanks’ Stock Analysis page.
